Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q2 2025 value amounting to $33000.0.

  • Lifecore Biomedical, Inc. \De\'s Tax Provisions rose 15789.47% to $33000.0 in Q2 2025 from the same period last year, while for May 2025 it was $43000.0, marking a year-over-year decrease of 7650.27%. This contributed to the annual value of $43000.0 for FY2025, which is 7650.27% down from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Tax Provisions of $33000.0 as of Q2 2025, which was up 15789.47% from -$8000.0 recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Tax Provisions registered a high of $3.4 million during Q1 2022, and its lowest value of -$6.3 million during Q4 2021.
  • Moreover, its 5-year median value for Tax Provisions was $4000.0 (2022), whereas its average is -$298777.8.
  • Within the past 5 years, the most significant YoY rise in Lifecore Biomedical, Inc. \De\'s Tax Provisions was 210000.0% (2023), while the steepest drop was 172500.0% (2023).
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Tax Provisions (Quarter) stood at -$6.3 million in 2021, then soared by 100.06% to $4000.0 in 2022, then crashed by 1725.0% to -$65000.0 in 2023, then soared by 166.15% to $43000.0 in 2024, then fell by 23.26% to $33000.0 in 2025.
  • Its last three reported values are $33000.0 in Q2 2025, -$8000.0 for Q1 2025, and $43000.0 during Q4 2024.